Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (491-500 of 761) with videos related to

Pageof 77
Sort By:
Thrombosis Research|November 30, 2004
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stentingDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
JACC. Cardiovascular Interventions|June 29, 2015
Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind InvestigationJung Rae Cho, Fabiana Rollini, Francesco Franchi, et al.
Circulation. Cardiovascular Interventions|March 10, 2011
Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery diseaseDavide Capodanno, Aasita Patel, Kodlipet Dharmashankar, et al.
European Heart Journal|July 23, 2024
Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registryJeehoon Kang, Junpil Yun, Kyung Woo Park, et al.
Thrombosis and Haemostasis|October 3, 2014
Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registryRoberta Rossini, Giuseppe Musumeci, Davide Capodanno, et al.
Diabetes|March 1, 2006
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery diseaseDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of Thrombosis and Thrombolysis|November 13, 2012
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitusAntonio Tello-Montoliu, Jose Luis Ferreiro, Murali K Kodali, et al.
JACC. Cardiovascular Interventions|August 25, 2018
Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary AngiographyRoxana Mehran, Michela Faggioni, Jaya Chandrasekhar, et al.
International Journal of Molecular Sciences|February 13, 2025
Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition?Salvatore Giordano, Marina Camera, Marta Brambilla, et al.
Journal of the American College of Cardiology|July 18, 2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentDominick J Angiolillo, Esther Bernardo, Celia Ramírez, et al.
Pageof 77

Showing results (491-500 of 761) with videos related to

Sort By:
Pageof 77
Thrombosis Research|November 30, 2004
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stentingDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
JACC. Cardiovascular Interventions|June 29, 2015
Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind InvestigationJung Rae Cho, Fabiana Rollini, Francesco Franchi, et al.
Circulation. Cardiovascular Interventions|March 10, 2011
Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery diseaseDavide Capodanno, Aasita Patel, Kodlipet Dharmashankar, et al.
European Heart Journal|July 23, 2024
Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registryJeehoon Kang, Junpil Yun, Kyung Woo Park, et al.
Thrombosis and Haemostasis|October 3, 2014
Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registryRoberta Rossini, Giuseppe Musumeci, Davide Capodanno, et al.
Diabetes|March 1, 2006
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery diseaseDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
Journal of Thrombosis and Thrombolysis|November 13, 2012
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitusAntonio Tello-Montoliu, Jose Luis Ferreiro, Murali K Kodali, et al.
JACC. Cardiovascular Interventions|August 25, 2018
Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary AngiographyRoxana Mehran, Michela Faggioni, Jaya Chandrasekhar, et al.
International Journal of Molecular Sciences|February 13, 2025
Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition?Salvatore Giordano, Marina Camera, Marta Brambilla, et al.
Journal of the American College of Cardiology|July 18, 2006
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatmentDominick J Angiolillo, Esther Bernardo, Celia Ramírez, et al.
Pageof 77